HealthEquity Inc Stock News

HealthEquity reported strong Q2 results with revenue and earnings beats, but valuation remains stretched, justifying a neutral-to-cautiously bullish rating. The company operates in a large, growing healthcare savings market, with solid account and asset growth driven mostly by organic expansion. Financial metrics were robust: revenue up 8.6%, adjusted EBITDA up 18%, and margin expansion, with c...

HealthEquity, Inc. (NASDAQ:HQY ) Q2 2026 Earnings Call September 2, 2025 4:30 PM EDT Company Participants Richard Putnam - Vice President of Investor Relations Scott Cutler - CEO, President & Director Stephen D. Neeleman - Founder & Vice Chairman James Lucania - CFO & Executive VP Conference Call Participants Brian Tanquilut - Jefferies LLC, Research Division Charles Peters - Raymond James & As...

HQY remains a buy for long-term investors, with exceptional economics, high margins, and capital-light growth despite recent multiple contraction. Q1 FY26 results showed strong revenue and earnings growth, margin expansion, and operating leverage, confirming the business is scaling efficiently. The recurring, asset-linked revenue model benefits from secular healthcare tailwinds, high switching ...

Industry Leader's HSAnswers Wins Multiple Awards to Transform Complex Healthcare Benefits Information to Accessible and Reliable Intel For Millions Industry Leader's HSAnswers Wins Multiple Awards to Transform Complex Healthcare Benefits Information to Accessible and Reliable Intel For Millions

Funding supports 20 nonprofit organizations focused on physical and mental health, financial literacy, and basic needs as the foundation grows and welcomes a new leader Funding supports 20 nonprofit organizations focused on physical and mental health, financial literacy, and basic needs as the foundation grows and welcomes a new leader

Insmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses, guidance cuts, and Medicare Advantage mispricing, despite its long-term potential to restore profitability. Thermo Fisher and argenx detracted from performance amid macro headwinds and lower-than...

DRAPER, Utah, Aug. 06, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest health savings account (“HSA") custodian, today announced plans to release its second quarter of fiscal 2026 financial results following the close of regular stock market trading hours on Tuesday, September 2, 2025. Following the news release, HealthEquity man...

Growth stocks can create significant returns for investors, but what are they and how do you find the best ones? We take a closer look here.